A survey of the gastropod Nucella lapillus around the south-west peninsula of England has revealed that the incidence of ‘imposex’, the induction of male sex characters in the female, is widespread, that all populations are affected to some degree and that the phenomenon is most prevalent along the south (Channel) coast. Populations close to centres of boating and shipping activity show the highest degrees of imposex, especially those within the vicinities of the Helford, Fal, Salcombe and Dart estuaries and in Plymouth Sound and Tor Bay. Within Plymouth Sound the degree of imposex increased markedly between 1969 and 1985, coinciding with the introduction and increasing usage of antifouling paints containing tributyltin (TBT) compounds.
The term ‘imposex’ was coined by Smith (1971) to describe the superimposition of male characters onto unparasitized and parasitized females of gonochoristic gastropods. In Nassarius obsoletus (Say) the development of imposex results in the female having one or more of the following characters: (1) a penis with a duct leading to (2) a vas deferens which passes back to the ventral channel of the capsule gland and (3) convolution of the normally straight gonadial oviduct (Smith, 1980). Imposex in the similarly gonochoristic Nucella lapillus (L.) was first noted by Blaber (1970) who found females with penis-like outgrowths in Plymouth Sound populations. Subsequent studies (Bryan et al. 1986; Gibbs & Bryan, 1986) have demonstrated that the incidence and intensity of imposex have since increased markedly in the same populations and that the phenomenon is widespread around south-west England.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.